These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review]. Munch G; Godart N Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720 [TBL] [Abstract][Full Text] [Related]
4. Treatment of bipolar depression: making sensible decisions. Citrome L CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667 [TBL] [Abstract][Full Text] [Related]
8. Bipolar II disorder : epidemiology, diagnosis and management. Benazzi F CNS Drugs; 2007; 21(9):727-40. PubMed ID: 17696573 [TBL] [Abstract][Full Text] [Related]
9. ECNP consensus meeting. Bipolar depression. Nice, March 2007. Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566 [TBL] [Abstract][Full Text] [Related]
10. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics. Selle V; Schalkwijk S; Vázquez GH; Baldessarini RJ Pharmacopsychiatry; 2014 Mar; 47(2):43-52. PubMed ID: 24549862 [TBL] [Abstract][Full Text] [Related]
11. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028 [TBL] [Abstract][Full Text] [Related]
12. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609 [TBL] [Abstract][Full Text] [Related]
13. Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat. Gao K; Yuan C; Wu R; Chen J; Wang Z; Fang Y; Calabrese JR Neurosci Bull; 2015 Oct; 31(5):572-88. PubMed ID: 26024955 [TBL] [Abstract][Full Text] [Related]
15. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165 [TBL] [Abstract][Full Text] [Related]
16. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393 [TBL] [Abstract][Full Text] [Related]
17. Balancing benefits and harms of treatments for acute bipolar depression. Ketter TA; Miller S; Dell'Osso B; Calabrese JR; Frye MA; Citrome L J Affect Disord; 2014 Dec; 169 Suppl 1():S24-33. PubMed ID: 25533911 [TBL] [Abstract][Full Text] [Related]
18. Maintenance therapies in bipolar disorder: focus on randomized controlled trials. Muzina DJ; Calabrese JR Aust N Z J Psychiatry; 2005 Aug; 39(8):652-61. PubMed ID: 16050919 [TBL] [Abstract][Full Text] [Related]
19. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed. Citrome L; Ketter TA; Cucchiaro J; Loebel A J Affect Disord; 2014 Feb; 155():20-7. PubMed ID: 24246116 [TBL] [Abstract][Full Text] [Related]
20. Acute and maintenance treatment with mood stabilizers. Bowden CL Int J Neuropsychopharmacol; 2003 Sep; 6(3):269-75. PubMed ID: 12974993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]